#BCSM Transcript
Healthcare social media transcript of the #BCSM hashtag.
– ().
See #BCSM Influencers/Analytics.
| Profile | Tweet |
|---|---|
 | 乳腺外科医 @anti_breastc RT @BreastCaConnect: New @Nature_NPJ study evaluates TILs as biomarkers in HER2+ #BreastCancer. Patients with TIL scores ≥60% showed excellent 3-year survival rates regardless of treatment. High TIL scores might indicate a favourable prognosis in stage II-III disease. #bcsm https://t.co/Zf5N5J24ma https://t.co/SUeajr7hyt |
 | Barbra Tugman @BarbraTugman RT @EvolvePink: Before you go to sleep, think about how you can fall in love with yourself again Good night everyone #bcsm #breastcancer https://t.co/KYXhx4UAey |
 | Dana-Farber’s Breast Oncology Center @DFCI_BreastOnc Check out the new #BreastCancer Research Digest - a summary of last week’s publications from select high-impact journals (April 15th-21st, 2024). #ClinicalResearch #CancerTreatment #BCSM #BreastCancerResearch https://t.co/Voe9hCgl25 |
 | Benjamin Walbaum, MD @benjiwal RT @DFCI_BreastOnc: Check out the new #BreastCancer Research Digest - a summary of last week’s publications from select high-impact journals (April 15th-21st, 2024). #ClinicalResearch #CancerTreatment #BCSM #BreastCancerResearch https://t.co/Voe9hCgl25 |
 | Evolve Pink @EvolvePink Start this week of right! #thinkpositive #bcsm #breastcancer #inspirationalquotes https://t.co/Ouxlo7mJrb |
 | Abigail Johnston, Esq (she/her) @AMJohnston1315 Extra Spoons, a Ritalin Experiment … https://t.co/r4seWzvsqz #bcsm |
 | Deb Maes❤️🧡💙 @deb_maes61 RT @AMJohnston1315: Extra Spoons, a Ritalin Experiment … https://t.co/r4seWzvsqz #bcsm |
 | Kazuki Nozawa @kazuki_nozawa RT @DFCI_BreastOnc: Check out the new #BreastCancer Research Digest - a summary of last week’s publications from select high-impact journals (April 15th-21st, 2024). #ClinicalResearch #CancerTreatment #BCSM #BreastCancerResearch https://t.co/Voe9hCgl25 |
 | learnlooklocate @learnlooklocate Learn Look Locate is thrilled to announce the release of its latest resource, “Doxorubicin: A Comprehensive Guide About Red Devil Chemotherapy.”https://t.co/R7SdTgQRcl #bcsm #breastcancer #chemotherapy #chemo #Oncology https://t.co/mNRjBIxIwL |
 | Case Comp Cancer Ctr @caseccc RT @TheDrWood: Grateful for our department @RadOncUH under the leadership of @DrSpratticus to receive a shoutout at the 2024 @UHhospitals State of Research Address by @DanSimonMD highlighting the success of @Lauren_Henke & the @DrMcClellandLab! #RadOnc #NAVAH #AdaptiveRT #bcsm #pcsm #KillCancer https://t.co/o215NtmJ0l |
 | Medidata @Medidata RT @marlajan: My heart is broken, I am numb. the world has lost one hell of a human being. Her last text to me was “Sisters for life.” Sisters for life, indeed. I love you Sheila. @swaggsheila1 #bcsm #breastcancer #medidata |
| Medidata @Medidata RT @stales: The #BCSM community is crushed by the news of @swaggsheila1's passing. God Speed, Sheila. |
 | Janice Cowden @JaniceTNBCmets RT @AMJohnston1315: Extra Spoons, a Ritalin Experiment … https://t.co/r4seWzvsqz #bcsm |
 | UH Research & Education Institute @UH_RE_Institute RT @TheDrWood: Grateful for our department @RadOncUH under the leadership of @DrSpratticus to receive a shoutout at the 2024 @UHhospitals State of Research Address by @DanSimonMD highlighting the success of @Lauren_Henke & the @DrMcClellandLab! #RadOnc #NAVAH #AdaptiveRT #bcsm #pcsm #KillCancer https://t.co/o215NtmJ0l |
| Medidata @Medidata RT @stage4kelly: Sheila @swaggsheila1 had the best smile. She was a woman of deep, deep faith. She was a veteran, a mom, a clinical trial champion, and she challenged the clinical trial machine to do better. She was a friend and I will miss her. #bcsm https://t.co/PL4WXF5y5i |
 | Chidambara .ML. @chidambara09 RT @learnlooklocate: Learn Look Locate is thrilled to announce the release of its latest resource, “Doxorubicin: Learn Look Locate is thrilled to announce the release of its latest resource, “Doxorubicin: A Comprehensive Guide About Red Devil Chemotherapy.”https://t.co/R7SdTgQRcl #bcsm #breastcancer #chemotherapy #chemo #Oncology https://t.co/mNRjBIxIwL |
 | Sara Tolaney @stolaney1 RT @DFCI_BreastOnc: Check out the new #BreastCancer Research Digest - a summary of last week’s publications from select high-impact journals (April 15th-21st, 2024). #ClinicalResearch #CancerTreatment #BCSM #BreastCancerResearch https://t.co/Voe9hCgl25 |
 | Andrea Merrill, MD FACS @AndreaLMerrill RT @chibaAkiko: The 10-year risk of developing a 2nd primary BC was ~2% among women who did not carry a germline pathogenic variant compared with ~9% among women with pathogenic variant. ❇️If no pathogenic variant, rate of 2nd primary is LOW! ❇️importance of genetic testing #bcsm https://t.co/rrTdlsKY49 |
 | Rodgers Kiplaa @KiplaaRodg25829 RT @EvolvePink: Truth! Don’t give up… #bcsm #breastcancer #inspirationalquotes https://t.co/RXJYFdS42p |
 | ECOG-ACRIN Cancer Research Group @eaonc Imagine a future where #breastcancer screening is tailored to your individual risk factors. The TMIST trial could help make this possible. Learn more: https://t.co/O3fHpNLruK #bcsm #TMIST4BC cc: @RadiologyACR @NCIprevention https://t.co/yuiwQanyA8 |
 | Mammography Saves @MammoSaves RT @eaonc: Imagine a future where #breastcancer screening is tailored to your individual risk factors. The TMIST trial could help make this possible. Learn more: https://t.co/O3fHpNLruK #bcsm #TMIST4BC cc: @RadiologyACR @NCIprevention https://t.co/yuiwQanyA8 |
 | Breast Cancer Research Foundation of Alabama @BCRFAlabama RT @cphilwil: Thank you to @BCRFAlabama and @ONealCancerUAB for their support! I'm thrilled to pursue this research aimed at reducing economic barriers to oncology #clinicaltrial participation for women with #breastcancer #bcsm @UABDeptMed |
 | She @ShehasMBC @lizard817 @emtrrt_cat @cwbic @ThanksCancer #bcsm who is in Virginia that can give a friend some help after bilateral mastectomy? |
 | IBC Research Fdn @IBCResearch Can Men Get Breast Cancer? We know that #men get #breastcancer but is the general public aware? #bcsm @OncoAlert https://t.co/YEeHD4BArt |
 | Amit Sehrawat @dramitsehrawat Tumor infiltrating lymphocytes in gastric cancer: Unraveling complex interactions for precision medicine. #WJCO #BCSM https://t.co/C88fISQmtH |
 | MRIDUL KHANNA @mridulkhanna91 RT @dramitsehrawat: Tumor infiltrating lymphocytes in gastric cancer: Tumor infiltrating lymphocytes in gastric cancer: Unraveling complex interactions for precision medicine. #WJCO #BCSM https://t.co/C88fISQmtH |
 | BREAST CANCER CONNECT @BreastCaConnect CGP shows promise in guiding genomically matched therapies for cancer patients. Rare cancer patients saw higher ORR, while early-line treatments post-profiling boosted therapeutic benefits across tumour types including #breastcancer. https://t.co/TPQFCcsnvq #MedEd #bcsm https://t.co/TpMkOhic8v |
 | BreastCancer Chat WW #BCCWW @bccww RT @IBCResearch: Can Men Get Breast Cancer? We know that #men get #breastcancer but is the general public aware? #bcsm @OncoAlert https://t.co/YEeHD4BArt |
 | Diane @Diane62710144 RT @hmcarthur: COUNTDOWN TO THE 2024 REVES BREAST CANCER SYMPOSIUM: 15 DAYS…Featuring a Keynote lecture by Dr. Elizabeth Mittendorf (@EMittendorfMD) on Breast Cancer Immunotherapy: Past, Present and Future Register today: https://t.co/auCbHwG93Z @utswcancer @CarlosArteagaMD @DVFelaine #bcsm |
| Evolve Pink @EvolvePink Remember this and if you know someone who is struggling, let them know When you see someone who made it through it can have a positive impact #bcsm #breastcancer #inspirationalquotes https://t.co/1AzQbC3Bsy |
 | Vladimir Villoslada Terrones @Villoslada_INEN RT @BreastCaConnect: CGP shows promise in guiding genomically matched therapies for cancer patients. Rare cancer patients saw higher ORR, while early-line treatments post-profiling boosted therapeutic benefits across tumour types including #breastcancer. https://t.co/TPQFCcsnvq #MedEd #bcsm https://t.co/TpMkOhic8v |
 | OncoAlert @OncoAlert RT @IBCResearch: Can Men Get Breast Cancer? We know that #men get #breastcancer but is the general public aware? #bcsm @OncoAlert https://t.co/YEeHD4BArt |
 | Pnkim @KimSchiffman RT @EvolvePink: Remember this and if you know someone who is struggling, let them know When you see someone who made it through it can have a positive impact #bcsm #breastcancer #inspirationalquotes https://t.co/1AzQbC3Bsy |
 | Mia Spano-Curtiss & Sondra Price @BSBreastCancer RT @AMJohnston1315: Extra Spoons, a Ritalin Experiment … https://t.co/r4seWzvsqz #bcsm |
 | CancerNetwork® @CancerNetwrk Roshni Rao, MD, FACS, highlights the role of clipping the lymph node of patients with node-positive breast cancer who underwent neoadjuvant chemotherapy. #bcsm | @nyphospital @ColumbiaMed @ASBrS https://t.co/2RQ4a1XxHv |
 | ACS Journal Cancer @JournalCancer Combination therapy with CDK and PD-L1 immune checkpoint inhibitors affects the immune microenvironment, promotes antitumor immunity, and improves the efficacy of immunotherapy for triple-negative breast cancer. https://t.co/NwMnPvKJQ7 @OncoAlert #BCSM https://t.co/8urHDzLZ1C |
 | ChandraKota,Ph.D. @RadOnc_AI RT @IBCResearch: Can Men Get Breast Cancer? We know that #men get #breastcancer but is the general public aware? #bcsm @OncoAlert https://t.co/YEeHD4BArt |
 | Living with Lobular Breast Cancer in Canada @lobbccanada RT @BreastCaConnect: CGP shows promise in guiding genomically matched therapies for cancer patients. Rare cancer patients saw higher ORR, while early-line treatments post-profiling boosted therapeutic benefits across tumour types including #breastcancer. https://t.co/TPQFCcsnvq #MedEd #bcsm https://t.co/TpMkOhic8v |
| OncoAlert @OncoAlert RT @JournalCancer: Combination therapy with CDK and PD-L1 immune checkpoint inhibitors affects the immune microenvironment, promotes antitumor immunity, and improves the efficacy of immunotherapy for triple-negative breast cancer. https://t.co/NwMnPvKJQ7 @OncoAlert #BCSM https://t.co/8urHDzLZ1C |
 | themusingsofspu @themusingsofspu RT @IBCResearch: Can Men Get Breast Cancer? We know that #men get #breastcancer but is the general public aware? #bcsm @OncoAlert https://t.co/YEeHD4BArt |
| Janice Cowden @JaniceTNBCmets Are you a #cancer Patient, Research, Policy or Community advocate? Are you a person diagnosed w/ (or history of) cancer interested in advocacy but not sure where to start? We need your voice & would love to have you join us! https://t.co/DDQZqny3XK #bcsm @AdvocateCollab |
 | Patricia Clark MD, FACS, FSSO @patriciaclarkmd RT @chibaAkiko: The 10-year risk of developing a 2nd primary BC was ~2% among women who did not carry a germline pathogenic variant compared with ~9% among women with pathogenic variant. ❇️If no pathogenic variant, rate of 2nd primary is LOW! ❇️importance of genetic testing #bcsm https://t.co/rrTdlsKY49 |
 | Genetic Technologies @Gene_type The risk of developing breast cancer combines many factors including family history, age, & polygenic risk, to calculate a single risk score. Dive deeper into understanding and explaining risk scores to your patients today: https://t.co/14oNjwMnYh #geneType #bcsm #KnowYourRisk https://t.co/osgQyMQhj3 |
 | Nancy's Point @NancysPoint RT @mmejendouglas: I feel anxiety every time I have a breast cancer doctor’s appointment on the calendar. In this latest post on @Healthgrades, I share how I manage my anxiety as the appointments approach. #Sponsored #bcsm https://t.co/21kuX6Cmzw |
 | Triage Cancer @TriageCancer #beyonddiagnosis #medicalbills #cancer #canceradvocacy #healthcarefinances #CancerAwareness #CancerPatient #CancerSurvivorship #CancerCare #CancerSurvivor #hcsm #ayacsm #lcsm #bcsm #btsm #pcsm #mmsm #oncology #PatientAdvocacy #NoOneFightsAlone |
| CancerNetwork® @CancerNetwrk “I’m just too enthusiastic about the data. If you have groups [with pCRs of] 3% vs over 55%, just biologically spoken, that must be something that can be solved by science, and we need to solve it." said Peter Fasching, MD. #bcsm https://t.co/JA5fRC9rNM |
 | OncologyNurseAdvisor @ONAcom Researchers found a potential beneficial sequential strategy for ADCs in the treatment of HER2-positive metastatic #breastCancer in T-Dxd followed by disitamab vedotin. Published in @oncjournal. https://t.co/iH0UhlHsM0 #BCSM |
 | Kimia Sorouri, MD, MPH @KimiaSorouriMD Thank you so much to @ASCO @ConquerCancerFd for supporting our work exploring fertility outcomes among breast cancer survivors. Forever grateful to the most incredible mentor @AnnPartridgeMD and the rest of the dream team for making this possible! #ASCO24 #bcsm @DFCI_BreastOnc https://t.co/EHS2vGBDW4 |
 | OncLive.com @OncLive Vepdegestrant Shows Potential in ESR1-Mutant ER+/HER2– Breast Cancer @DrDebuTripathy @mdandersonnews @sabcssanantonio #bcsm https://t.co/3UypkJBw1g |
| Dana-Farber’s Breast Oncology Center @DFCI_BreastOnc RT @KimiaSorouriMD: Thank you so much to @ASCO @ConquerCancerFd for supporting our work exploring fertility outcomes among breast cancer survivors. Forever grateful to the most incredible mentor @AnnPartridgeMD and the rest of the dream team for making this possible! #ASCO24 #bcsm @DFCI_BreastOnc https://t.co/EHS2vGBDW4 |
 | Cancer Support Equal Hope @CancersupportEH See how you can manage your skin! https://t.co/BKJhg90Wt4 Visit https://t.co/ciAGRSCacO for more handouts, like Equal Hope #Cancer Support on #Facebook and follow cancersupporteh on #Twitter! #bcsm https://t.co/EmFFfFnWF1 |
| Mia Spano-Curtiss & Sondra Price @BSBreastCancer RT @EvolvePink: Remember this and if you know someone who is struggling, let them know When you see someone who made it through it can have a positive impact #bcsm #breastcancer #inspirationalquotes https://t.co/1AzQbC3Bsy |
 | Hillary (Stires) Andrews, PhD @HillStirSci RT @JaniceTNBCmets: Are you a #cancer Patient, Research, Policy or Community advocate? Are you a person diagnosed w/ (or history of) cancer interested in advocacy but not sure where to start? We need your voice & would love to have you join us! https://t.co/DDQZqny3XK #bcsm @AdvocateCollab |
 | Jamie @GEInc_ RT @Gene_type: The risk of developing breast cancer combines many factors including family history, age, & polygenic risk, to calculate a single risk score. Dive deeper into understanding and explaining risk scores to your patients today: https://t.co/14oNjwMnYh #geneType #bcsm #KnowYourRisk https://t.co/osgQyMQhj3 |
 | The Oncology Post @theoncologypost RT @JaniceTNBCmets: Are you a #cancer Patient, Research, Policy or Community advocate? Are you a person diagnosed w/ (or history of) cancer interested in advocacy but not sure where to start? We need your voice & would love to have you join us! https://t.co/DDQZqny3XK #bcsm @AdvocateCollab |
 | Cancer Nursing Today @cancer_nurses 🏥 What can happen when you reduce the time toxicity associated with breast cancer treatment? 🗨️ Experts from @MSKCancerCenter, @NYOHPC, @LifespanHlthSys, & Florida Cancer Specialists share their insights in this roundtable series. 📺 Watch now: https://t.co/xicFv440kB #bcsm https://t.co/NAW2Xf8UzG |
 | Marina @4RiseUp RT @JaniceTNBCmets: Are you a #cancer Patient, Research, Policy or Community advocate? Are you a person diagnosed w/ (or history of) cancer interested in advocacy but not sure where to start? We need your voice & would love to have you join us! https://t.co/DDQZqny3XK #bcsm @AdvocateCollab |
 | Targeted Oncology @TargetedOnc Hope S. Rugo, MD, FASCO, moderated a discussion on treatment options for a patient whose breast cancer recurred several years after adjuvant therapy. #BCSM | @UCSFCancer @hoperugo https://t.co/2mmcgqxOKw https://t.co/BHKm7VgSf5 |
 | MBC Advocate @MBCadvocate TransCode Therapeutics Announces FDA Clearance To Initiate Phase 1/2 Clinical Trial with TTX-MC138 in Patients with Advanced Solid Tumors. $RNAZ #MBC #bcsm https://t.co/yxM1tPXHxL |
 | 🏔Mandy (she/her) 🌲🍁🍂🌸🍨🍺 @DMandzz Waiting room feet at the cancer center! My feet r so Tony compared to hubs! 😂 @ThanksCancer #bcsm #lobular #carcinomies https://t.co/yRMypdxGTA |
| MBC Advocate @MBCadvocate Hyundai Bioscience announces its successful result from a preclinical study of a Niclosamide-based oral anticancer drug to treat TNBC. Please expedite Er+Her2- metastatic breast cancer also. #MBC #bcsm https://t.co/42JQN1JAOy |
| MBC Advocate @MBCadvocate Early Detection of Myeloid-Derived Suppressor Cells in the Lung Pre-Metastatic Niche by Shortwave Infrared Nanoprobes with Metastatic Breast Cancer. #MBC #bcsm https://t.co/IXzKkCUibr |
 | Julie Eberle @Juliemamafor3 @chibaAkiko We know the 72% of women with low risk DCIS are not going to recur after surgery alone. Why are so many treated with RT? #bcsm #JAMA #DeadpoolAndWolverine #breastcancer |
 | Maelli🇺🇦🌻🟧 @Maelli14 RT @JaniceTNBCmets: Are you a #cancer Patient, Research, Policy or Community advocate? Are you a person diagnosed w/ (or history of) cancer interested in advocacy but not sure where to start? We need your voice & would love to have you join us! https://t.co/DDQZqny3XK #bcsm @AdvocateCollab |
| MBC Advocate @MBCadvocate NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer. $PBYI #MBC #bcsm https://t.co/uHgx9kgirG |
| Living with Lobular Breast Cancer in Canada @lobbccanada RT @JaniceTNBCmets: Are you a #cancer Patient, Research, Policy or Community advocate? Are you a person diagnosed w/ (or history of) cancer interested in advocacy but not sure where to start? We need your voice & would love to have you join us! https://t.co/DDQZqny3XK #bcsm @AdvocateCollab |
 | Alicia C. Staley @stales RT @JaniceTNBCmets: Are you a #cancer Patient, Research, Policy or Community advocate? Are you a person diagnosed w/ (or history of) cancer interested in advocacy but not sure where to start? We need your voice & would love to have you join us! https://t.co/DDQZqny3XK #bcsm @AdvocateCollab |
 | Thanks Cancer! @ThanksCancer RT @DMandzz: Waiting room feet at the cancer center! My feet r so Tony compared to hubs! 😂 @ThanksCancer #bcsm #lobular #carcinomies https://t.co/yRMypdxGTA |
 | UCSF Helen Diller Family Comprehensive Cancer Ctr @UCSFCancer RT @TargetedOnc: Hope S. Rugo, MD, FASCO, moderated a discussion on treatment options for a patient whose breast cancer recurred several years after adjuvant therapy. #BCSM | @UCSFCancer @hoperugo https://t.co/2mmcgqxOKw https://t.co/BHKm7VgSf5 |
| Evolve Pink @EvolvePink Good night everyone #bcsm #breastcancer https://t.co/bFT3z6fTvE |
 | NCI Cancer Stats @NCICancerStats In 2024, there will be about 310,720 new cases of female #BreastCancer in the US. Breast cancer is the most commonly diagnosed invasive cancer. Visit our Cancer Stat Facts sheet to learn more: https://t.co/wUKAVg2gqh #BCSM https://t.co/GHy5KpNVye |
 | José M Peñaloza @maur_jmp RT @BreastCaConnect: 🌸🎗️@TheLancet Breast Cancer Commission have put together a powerful road map addressing prevention, personalized treatment, collaboration, and patient empowerment. Highly recommended reading for clinicians and patients alike. #bcsm #MedEd https://t.co/wwNvy1OCn5 https://t.co/YV44HLIeCw |
| MBC Advocate @MBCadvocate Issue of Equity and Total Voting Rights.“The Board carefully considered the difficult balance between further dilution and the Group’s cash resources to deliver key value adding milestones from the upcoming #AVA6000 efficacy studies.” #MBC #bcsm #AVCT https://t.co/PM6TRzpRQR |
| Barbra Tugman @BarbraTugman RT @EvolvePink: Good night everyone #bcsm #breastcancer https://t.co/bFT3z6fTvE |
| Barbra Tugman @BarbraTugman RT @EvolvePink: Remember this and if you know someone who is struggling, let them know When you see someone who made it through it can have a positive impact #bcsm #breastcancer #inspirationalquotes https://t.co/1AzQbC3Bsy |
 | Angel Puss ☔️🌷🌱 @Angel__Puss RT @EvolvePink: Remember this and if you know someone who is struggling, let them know When you see someone who made it through it can have a positive impact #bcsm #breastcancer #inspirationalquotes https://t.co/1AzQbC3Bsy |
 | Indira W. Martínez Nieto @Mastolo_gyn RT @chibaAkiko: The 10-year risk of developing a 2nd primary BC was ~2% among women who did not carry a germline pathogenic variant compared with ~9% among women with pathogenic variant. ❇️If no pathogenic variant, rate of 2nd primary is LOW! ❇️importance of genetic testing #bcsm https://t.co/rrTdlsKY49 |
 | Journal of Nutritional Oncology @JNOjournal RT @JournalCancer: Combination therapy with CDK and PD-L1 immune checkpoint inhibitors affects the immune microenvironment, promotes antitumor immunity, and improves the efficacy of immunotherapy for triple-negative breast cancer. https://t.co/NwMnPvKJQ7 @OncoAlert #BCSM https://t.co/8urHDzLZ1C |
 | Nancy M @TLCOMPASSION RT @stage4kelly: So. Much. This. @taylorswift13 @taylornation13 #MetastaticBreastCancer #bcsm #lcsm #crcsm #btsm #gyncsm #melsm https://t.co/1azknYHpew |
#BCSM content from Twitter.